Skip to main content
Medical information Clinical review pending

Haematology Testing

Activated Protein C Resistance (APCR) Test

The Activated Protein C Resistance (APCR) Test assesses your risk for thromboembolic disorders like blood clots. It measures how well your blood responds to activated protein C, a natural anticoagulant.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL whole blood in a Blue Top (Sodium Citrate) tube.
Results
Confirm with the laboratory before booking.
Preparation
Inform your doctor about all medications you are taking, especially anticoagulants (like Heparin or Warfarin). You may need to temporarily stop certain medications before the test. Confirm specific instructions with your physician and the laboratory before booking.
Test priceKSh 10,400

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Activated Protein C Resistance (APCR) Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Personal or family history of venous thromboembolism (VTE)
  • ✓Unexplained blood clots
  • ✓Recurrent miscarriages
  • ✓Patients on anticoagulant therapy
  • ✓Evaluation before certain surgeries or hormone therapy
02

In plain language

What this test helps you understand

To assess the risk of developing thromboembolic disorders (blood clots).
The Activated Protein C Resistance (APCR) Test is a diagnostic tool used to evaluate the risk of thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. Understanding your risk factors is important for preventative health measures. This test measures the resistance of blood to the anticoagulant effects of activated protein C. High resistance suggests an increased risk for developing abnormal blood clots. This test can provide valuable insights into your health, helping identify genetic predispositions to clotting disorders and guiding treatment plans for those at risk. Results help you and your healthcare provider understand your risk level for thromboembolic events, aiding in informed health decisions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationInform your doctor about all medications you are taking, especially anticoagulants (like Heparin or Warfarin). You may need to temporarily stop certain medications before the test. Confirm specific instructions with your physician and the laboratory before booking.
Sample3 mL whole blood in a Blue Top (Sodium Citrate) tube.
MethodologyCoagulation assay measuring clotting time in the presence of activated protein C.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test measures resistance to activated protein C but does not identify the specific genetic mutation causing the resistance. Other factors contribute to clotting risk. Results should be interpreted in the context of your overall clinical picture.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

It's a condition where the blood doesn't respond normally to activated protein C, a natural substance that helps prevent blood clots. This resistance can increase the risk of developing clots.
It helps identify individuals at a higher risk for thromboembolic disorders (blood clots), allowing for potential preventative measures or adjustments to treatment plans.
Individuals with a personal or family history of blood clots, unexplained clotting events, or recurrent miscarriages may be advised to take this test by their doctor.
You may need to stop certain medications, particularly anticoagulants, for a period before the test. Please consult your doctor and the laboratory for specific instructions.
A positive result indicates resistance to activated protein C, suggesting an increased risk for blood clots. Your doctor will interpret this result alongside your medical history.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp